Ablacon Company
Ablacon is a provider of AI-guided atrial fibrillation therapies.
Total Funding:
$6.8B
Headquarters:
Wheat Ridge, Colorado, United States
Estimated Revenue:
$50M to $100M
Last Funding Type:
Post-IPO Equity
Technology:
['BioTech & HealthTech']
Investor Type:
contact@ablacon.com
Investors Number:
7
Founded Date:
2015
Industry:
Med Tech